Evolent Health (NYSE:EVH) Issues Earnings Results, Misses Estimates By $0.35 EPS

Evolent Health (NYSE:EVH) issued its quarterly earnings results on Thursday. The technology company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.38 by ($0.35), Zacks reports. Evolent Health had a positive return on equity of 5.73% and a negative net margin of 2.41%. The business had revenue of $646.54 million during the quarter, compared to analyst estimates of $650.92 million. Evolent Health updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

Evolent Health Stock Performance

Shares of Evolent Health stock opened at $10.44 on Friday. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of -12.73 and a beta of 1.45. The business has a 50-day moving average of $10.75 and a 200 day moving average of $18.85. Evolent Health has a 12 month low of $9.45 and a 12 month high of $35.00.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Canaccord Genuity Group lowered their price target on Evolent Health from $23.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, January 23rd. Oppenheimer cut their target price on Evolent Health from $28.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Royal Bank of Canada lowered their price target on shares of Evolent Health from $20.00 to $17.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 14th. Truist Financial dropped their price objective on shares of Evolent Health from $20.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, January 22nd. Finally, Citigroup dropped their price target on shares of Evolent Health from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $17.79.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.